FDA Discovers Contaminated Products, Unsterile Conditions at Ameridose
The report details a string of shortcomings, including ineffective drugs, unsterile or dilapidated environmental conditions and wildlife, at Ameridose. Sister company NECC is at the center of a federal investigation into a meningitis outbreak believed to be linked to contaminated NECC products. So far, the outbreak has claimed 32 lives and more than 400 meningitis illnesses.
Ameridose has already voluntarily recalled its products in late October after the FDA reported the company could not demonstrate product sterility and safety.
More Articles on Patient Safety:4 Risk Factors for Immediate Use Sterilization
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Why ASCs should prioritize personalities in staff recruitment: Select Physicians Surgery Center's administrator shares insight
- AAAHC names Dr. Vicky Gordon interim president & CEO: 3 notes
- Emergent BioSolutions receives contract for Zika vaccine: 4 things know
- Obama administration to update Medicare Part B payment proposal, but will this be enough to squash opposition?
- Illinois Department of Insurance approves $37B Aetna, Humana merger: 4 key points